299 related articles for article (PubMed ID: 24511547)
1. Phytochemical and pharmacological properties of Gymnema sylvestre: an important medicinal plant.
Tiwari P; Mishra BN; Sangwan NS
Biomed Res Int; 2014; 2014():830285. PubMed ID: 24511547
[TBL] [Abstract][Full Text] [Related]
2. In vitro Inhibitory Effect of Gymnema sylvestre Extracts and Total Gymnemic Acids Fraction on Select Cytochrome P450 Activities in Rat Liver Microsomes.
Vaghela M; Iyer K; Pandita N
Eur J Drug Metab Pharmacokinet; 2018 Apr; 43(2):227-237. PubMed ID: 29019074
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-assisted extraction of gymnemic acids from Gymnema sylvestre leaves and its effect on insulin-producing RINm-5 F β cell lines.
Sheoran S; Panda BP; Admane PS; Panda AK; Wajid S
Phytochem Anal; 2015; 26(2):97-104. PubMed ID: 25469471
[TBL] [Abstract][Full Text] [Related]
4. Biotechnological approaches for the production of gymnemic acid from Gymnema sylvestre R. Br.
Al-Khayri JM; Sudheer WN; Banadka A; Lakshmaiah VV; Nagella P; Al-Mssallem MQ; Alessa FM; Rezk AA
Appl Microbiol Biotechnol; 2023 Jul; 107(14):4459-4469. PubMed ID: 37266583
[TBL] [Abstract][Full Text] [Related]
5. C-4 gem-dimethylated oleanes of Gymnema sylvestre and their pharmacological activities.
Di Fabio G; Romanucci V; Zarrelli M; Giordano M; Zarrelli A
Molecules; 2013 Dec; 18(12):14892-919. PubMed ID: 24304585
[TBL] [Abstract][Full Text] [Related]
6. Production of Gymnemic Acid from Cell Suspension Cultures of Gymnema sylvestre.
Nagella P; Dandin VS; Murthy HN
Methods Mol Biol; 2016; 1391():229-39. PubMed ID: 27108321
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory Effect of Gymnema sylvestre (R.Br.) Leaf Extract: An In Vitro Study in Rat Model.
Singh VK; Dwivedi P; Chaudhary BR; Singh R
PLoS One; 2015; 10(10):e0139631. PubMed ID: 26474420
[TBL] [Abstract][Full Text] [Related]
8. Potential anticancer properties of bioactive compounds of Gymnema sylvestre and its biofunctionalized silver nanoparticles.
Arunachalam KD; Arun LB; Annamalai SK; Arunachalam AM
Int J Nanomedicine; 2015; 10():31-41. PubMed ID: 25565802
[TBL] [Abstract][Full Text] [Related]
9. Discrimination of different geographic varieties of Gymnema sylvestre, an anti-sweet plant used for the treatment of type 2 diabetes.
Pham HTT; Hoang MC; Ha TKQ; Dang LH; Tran VO; Nguyen TBT; Lee CH; Oh WK
Phytochemistry; 2018 Jun; 150():12-22. PubMed ID: 29529525
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Review on Phytochemicals, Pharmacological and Clinical Potentials of
Khan F; Sarker MMR; Ming LC; Mohamed IN; Zhao C; Sheikh BY; Tsong HF; Rashid MA
Front Pharmacol; 2019; 10():1223. PubMed ID: 31736747
[No Abstract] [Full Text] [Related]
11. Gymnema sylvestre for Diabetes: From Traditional Herb to Future's Therapeutic.
Tiwari P; Ahmad K; Baig MH
Curr Pharm Des; 2017; 23(11):1667-1676. PubMed ID: 27834124
[TBL] [Abstract][Full Text] [Related]
12. Recent developments made in the assessment of the antidiabetic potential of gymnema species - From 2016 to 2020.
Kahksha ; Alam O; Naaz S; Sharma V; Manaithiya A; Khan J; Alam A
J Ethnopharmacol; 2022 Mar; 286():114908. PubMed ID: 34906636
[TBL] [Abstract][Full Text] [Related]
13. Anti-obesity effect of Gymnema sylvestre extract on high fat diet-induced obesity in Wistar rats.
Kumar V; Bhandari U; Tripathi CD; Khanna G
Drug Res (Stuttg); 2013 Dec; 63(12):625-32. PubMed ID: 23842942
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of Gymnema sylvestre in obesity and diabetes management.
Pothuraju R; Sharma RK; Chagalamarri J; Jangra S; Kumar Kavadi P
J Sci Food Agric; 2014 Mar; 94(5):834-40. PubMed ID: 24166097
[TBL] [Abstract][Full Text] [Related]
15. Fecal steroid excretion is increased in rats by oral administration of gymnemic acids contained in Gymnema sylvestre leaves.
Nakamura Y; Tsumura Y; Tonogai Y; Shibata T
J Nutr; 1999 Jun; 129(6):1214-22. PubMed ID: 10356090
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory and antioxidant activities of Gymnema Sylvestre extract rescue acute respiratory distress syndrome in rats via modulating the NF-κB/MAPK pathway.
Jangam A; Tirunavalli SK; Adimoolam BM; Kasireddy B; Patnaik SS; Erukkambattu J; Thota JR; Andugulapati SB; Addlagatta A
Inflammopharmacology; 2023 Apr; 31(2):823-844. PubMed ID: 36662401
[TBL] [Abstract][Full Text] [Related]
17. Effects of Gymnema sylvestre extract on the pharmacokinetics and pharmacodynamics of glimepiride in streptozotocin induced diabetic rats.
Kamble B; Gupta A; Moothedath I; Khatal L; Janrao S; Jadhav A; Duraiswamy B
Chem Biol Interact; 2016 Feb; 245():30-8. PubMed ID: 26721197
[TBL] [Abstract][Full Text] [Related]
18. Hypoglycaemic activity of an indigenous drug (Gymnema sylvestre, 'Gurmar') in normal and diabetic persons.
Khare AK; Tondon RN; Tewari JP
Indian J Physiol Pharmacol; 1983; 27(3):257-8. PubMed ID: 6668058
[No Abstract] [Full Text] [Related]
19. Possible biochemical effects following inhibition of ethanol-induced gastric mucosa damage by Gymnema sylvestre in male Wistar albino rats.
Al-Rejaie SS; Abuohashish HM; Ahmed MM; Aleisa AM; Alkhamees O
Pharm Biol; 2012 Dec; 50(12):1542-50. PubMed ID: 22978267
[TBL] [Abstract][Full Text] [Related]
20. A molecular connection of Pterocarpus marsupium, Eugenia jambolana and Gymnema sylvestre with dipeptidyl peptidase-4 in the treatment of diabetes.
Kosaraju J; Dubala A; Chinni S; Khatwal RB; Satish Kumar MN; Basavan D
Pharm Biol; 2014 Feb; 52(2):268-71. PubMed ID: 24074231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
